tradingkey.logo
tradingkey.logo
Search

Drugs Made In America Acquisition II Ord Shs

DMII
Add to Watchlist
10.095USD
+0.005+0.05%
Close 07-23 16:00ETQuotes delayed by 15 min
643.05MMarket Cap
26.26P/E TTM

DMII Financials

See Drugs Made In America Acquisition II Ord Shs's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Drugs Made In America Acquisition II Ord Shs Earnings Date

Latest Release
May 14, 2026
EPS / Forecast
--/--
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
0.32
10745.61%
Analyst Rating
--
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
Financial Indicators
EPS
--0.07
--0.67
--0.00
Net Profit
--4.34M
--4.33M
---46.16K
Debt to assets ratio
--0.09%
----
--0.00%
Operating profit
---132.03K
---1.05M
---155.51K
Net Profit
--4.34M
--4.33M
---46.16K
Current assets
--351.76K
--26.04K
--896.36K
Total current liabilities
--666.28K
--300.86K
--677.35K
Total assets
--509.73M
--504.96M
--501.01M
Total liabilities
--18.17M
--17.80M
--18.18M
Total equity
--491.56M
--487.16M
--482.83M
Net operating income
---102.50K
---314.86K
---690.73K
Net investment
----
--0.00
---500.00M
Net financing
--450.00K
--0.00
--501.00M

FAQs

What are the current assets of Drugs Made In America Acquisition II Ord Shs?

According to Drugs Made In America Acquisition II Ord Shs's FY2025 earnings report, its current assets were 26.04K, with a year-on-year change of -56.32.

What are the total assets of Drugs Made In America Acquisition II Ord Shs?

According to Drugs Made In America Acquisition II Ord Shs's FY2025 earnings report, its total assets of Drugs Made In America Acquisition II Ord Shs were 504.96M, with a year-on-year change of 365643.31.

What are the total liabilities of Drugs Made In America Acquisition II Ord Shs?

According to Drugs Made In America Acquisition II Ord Shs's FY2025 earnings report, its total liabilities of Drugs Made In America Acquisition II Ord Shs were 17.80M, with a year-on-year change of 6886.68.

What is the total equity of Drugs Made In America Acquisition II Ord Shs?

According to Drugs Made In America Acquisition II Ord Shs's FY2025 earnings report, its total equity of Drugs Made In America Acquisition II Ord Shs was 487.16M, with a year-on-year change of 417477.61.

What is the net operating income of Drugs Made In America Acquisition II Ord Shs?

According to Drugs Made In America Acquisition II Ord Shs's FY2025 earnings report, its net operating income of Drugs Made In America Acquisition II Ord Shs was -488.38K, with a year-on-year change of -221.90.

What is the net financing of Drugs Made In America Acquisition II Ord Shs?

According to Drugs Made In America Acquisition II Ord Shs's FY2025 earnings report, its net financing of Drugs Made In America Acquisition II Ord Shs was 501.00M, with a year-on-year change of 236966.17.

What is the Earnings Per Share (EPS) of Drugs Made In America Acquisition II Ord Shs?

According to Drugs Made In America Acquisition II Ord Shs's FY2025 earnings report, its Earnings Per Share (EPS) was 0.32, with a year-on-year change of 10745.61.

What is the net income of Drugs Made In America Acquisition II Ord Shs?

According to Drugs Made In America Acquisition II Ord Shs's FY2025 earnings report, its net income was 4.19M, with a year-on-year change of 2859.74.

What is the operating profit of Drugs Made In America Acquisition II Ord Shs?

According to Drugs Made In America Acquisition II Ord Shs's FY2025 earnings report, its operating profit was -488.38K, with a year-on-year change of -221.90.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.